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Abstract 
Anterior patterning in Drosophila is mediated by the localization of bicoid (bcd) mRNA at the 
anterior pole of the oocyte. Exuperantia (Exu) is a putative exonuclease (EXO) associated with 
bcd and required for its localization. We present the crystal structure of Exu that reveals a dimeric 
assembly with each monomer consisting of a 3'-5' EXO-like domain and a Sterile Alpha Motif 
(SAM)-like domain. The catalytic site is degenerated and inactive. Instead, the EXO-like domain 
mediates dimerization and RNA binding. We show that Exu binds RNA directly in vitro, that the 
SAM-like domain is required for RNA binding activity and that Exu binds to a structured 
element present in bcd 3'UTR with high affinity. Using structure-guided mutagenesis, we show 
that Exu dimerization is essential for bcd localization. Our data demonstrate that Exu is a non-
canonical RNA binding protein with EXO-SAM-like domain architecture that interacts with its 
target RNA as a homodimer.  
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Introduction 
Intracellular localization of mRNAs is a conserved mode of gene expression regulation in 
eukaryotes found in many cell types and processes1-5. mRNA localization targets the synthesis of 
specific proteins to their cytoplasmic site of function and provides fine temporal and spatial 
control of gene expression. As many copies of the encoded protein can be translated from a 
single mRNA molecule, the localization of specific transcripts can lead to a local enrichment of 
the protein and simultaneously prevents ectopic translation. mRNA localization is driven by the 
cooperative interactions between RNA signals on the localizing transcript, proteins that recognize 
these signals (mRNP components or trans-acting factors) and components of the cytoskeleton. 
 
Drosophila melanogaster early development is a well-characterized model system for mRNA 
localization6. In the oocyte and early embryo, a substantial proportion of all mRNAs are 
localized7,8. The oocyte relies on nurse cells for the import of cytoplasmic proteins and RNAs9,10. 
In the oocyte, localized maternal mRNAs such as bicoid (bcd), gurken (grk) and oskar (osk) 
determine the body axes of the embryo and future fly prior to fertilization11.  
Bcd, a transcription factor translated from the anteriorly localized bcd mRNA12,13, generates a 
morphogen gradient along the embryonic anteroposterior axis, defining the head and thoracic 
segments14. Proper bcd localization involves several, partially redundant, steps15. In early 
oogenesis (stage 5-6), bcd is actively transported from nurse cells. By mid-oogenesis (stage 8), 
bcd is restricted to the anterior of the oocyte in a tight ring by an active mechanism that requires 
maternal Exuperantia (Exu)15-17. Finally, at stage 10b, bcd redistributes into a disc associated with 
the anterior cortex18 and is translated after egg deposition and transcript polyadenylation19-21. 
 
Exu is thus known to be required for bcd localization from the earliest stages of oogenesis. In exu 
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mutants, bcd is transported to the oocyte but fails to accumulate at the anterior end, resulting in 
loss of head structures and an expanded thorax, a phenotype similar to weak bcd mutants13,15,16,22. 
Exu is required in nurse cells for the assembly of a bcd mRNP complex competent for correct 
localization23. Exu is enriched in the nurse cells at electron dense structures, the sponge bodies, 
and at tubular ER, and assembles into bcd mRNA containing particles that are transported to the 
oocyte in a dynein-dependent manner17,23-28.  
Exu co-purifies in a large ribonucleoprotein particle that includes the proteins Ypsilon schachtel 
(Yps), Me31B and Cup with osk, but not bcd, mRNA29,30. However, exu mutants show only 
transient mislocalization of osk mRNA that is compensated later in oogenesis22,29.  
 Although bcd is a paradigm for mRNA localization studies and the requirement for Exu in this 
process has been known for almost 30 years, the molecular function of Exu is poorly understood.  
 
Exu, which is conserved in insects, is predicted to have a 3'-5' exoribonuclease domain (EXO) 
from the DEDD exonuclease superfamily31. The EXO domain is found in several enzymes 
involved in RNA metabolism, including many essential in RNA and DNA maturation and 
degradation in prokaryotes and eukaryotes32. Whether exonucleolytic activity is important for 
Exu function is unknown. 
Exu C-terminal region (CTR) is predicted to be natively unstructured and is phosphorylated by 
Par-1, a Ser/Thr protein kinase33. Phosphorylation site mutants have a weak bcd localization 
defect that is compensated later in oogenesis33. 
Exu has been shown to cross-link to RNA in vitro34. However, since it has no predicted canonical 
RNA binding motifs, it was proposed to associate with bcd via an adapter protein34. Neither the 
RNA-binding region nor the sequence specificity has been determined25. 
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To further understand the role of Exu in mRNA localization we determined crystal structures of 
Drosophila Exu with and without the SAM-like domain. The structures show that the protein 
homodimerizes by interdigitating with itself. The EXO-like domain lacks the signature EXO 
sequence motifs and contributes instead to RNA binding. The SAM-like domain is also required 
for RNA binding and in vivo activity. We show that dimerization is essential for high affinity 
interactions with bcd 3'UTR motifs in vitro and Exu function in vivo.  
 
 
Results 
Structure determination and quality 
Attempts to crystallize full-length Exu were unsuccessful. Limited proteolysis generates two 
stable fragments that are truncated from the C-terminal end of the protein. Therefore, deletion 
constructs of Exu were used that include the residues from 1 to 333 (Exu333) and from 1 to 406 
(Exu406) (Fig. 1a). In the latter, a 60 amino acid (aa) non-conserved loop (loop 1), was mutated to 
a shorter (5 aa) loop present in the Exu ortholog from Bombyx mori (Supplementary Fig. 1). We 
determined the crystal structures of Exu333 and Exu406 at 2.37 Å and 2.80 Å resolution, 
respectively. The structure of SeMet-substituted Exu333 was solved by single wavelength 
anomalous dispersion (SAD). The refined Exu333 model has an Rfree of 22.3% and Rfactor of 
20.4% with good stereochemistry (Table 1). In the final model, 25 residues at the N-terminus, 11 
at the C-terminus and two loop regions, including loop1, are disordered (Fig. 1b-c). The Exu333 
model was then used as molecular replacement (MR) model to obtain phases for native Exu406 
crystals. Additional electron density observed in these crystals allowed the SAM-like C-terminal 
domain to be built. In the structure of Exu406, the N- and C-termini and some loop regions, 
including loop1 in molecule A, are disordered (Fig. 1d-e). The asymmetric unit (ASU) of this 
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crystal form includes two molecules in a dimeric assembly. The refined Exu406 model has an 
Rfree of 27.6% and Rfactor of 25.2% with good stereochemistry (Table 1). In molecule B, the 
SAM-like domain could only be partially modeled, accounting for the relatively high Rfree and B 
factors for this chain (Table 1).  
 
Overview of the structure 
Exu is a dimer that resembles a Greek cross with all arms of similar length: 85 Å vertical width 
(distance between residue 335 of each SAM-like domain) and 86 Å horizontal width (distance 
between residue 278 of each EXO-like domain). The two domains in each monomer form 
orthogonal arms of the cross (Fig. 1d). 
The EXO-like domain has a typical EXO fold, consistent with prior bioinformatic predictions31. 
A mixed α/β arrangement of secondary structure elements35,36 is organized into a curved 
antiparallel β-sheet (made of 5 antiparallel β-strands) flanked on each side by 4 α-helices (Fig. 
1). The β-sheet is capped on one side by a small α-helix and by an Exu-specific β-hairpin 
extension (Fig. 1). 
The SAM-like domain is a 5 helix-bundle with structural similarity to the Sterile Alpha Motif 
(SAM)-like fold (SCOP 47768) (Supplementary Fig. 2). A 32 Å-long helix connects the two 
domains. All independent observations of the EXO domain monomers (one molecule in Exu333 
ASU and two molecules in Exu406 ASU) are highly similar (RMSD of 0.34 Å over 2441 atoms), 
suggesting that the EXO dimer acts as a rigid scaffold. Similarly, the linker helix packs tightly 
against the EXO domain and shows limited structural variation in the three monomers.  
 
Exu is not an exonuclease 
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Database searches with PDBefold37 detect high structural similarity of the EXO-like domain of 
Exu with the mouse 3'-5' DEDD exonuclease Trex1 (Z-score = 9.2) (Fig. 2). 3'-5' exonucleases 
digest nucleic acids from the 3' end hydrolyzing one nucleotide at a time using a two-metal ion 
mechanism36,41-43. The four conserved metal binding residues (DEDD) of the EXO family proteins 
and a general base residue are distributed across three identifiable motifs, Exo I, II and III 
(Supplementary Fig. 3a). Structure-based alignment with Trex1 and RNaseT and inspection of 
the putative active site of Exu reveal, however, that key catalytic residues are not conserved and 
the metal binding site is disorganized. This suggests that Exu is unlikely to perform nucleic acid 
degradation by the same mechanism as other EXO domain-containing proteins (Fig. 2; 
Supplementary Fig. 3). Two of the four acidic residues required for activity are present in Exu, 
Asp39 and Asp41, corresponding to Asp18 and Glu20 in mouse Trex1. However, residues 
equivalent to the remaining negatively charged residues (Asp130 and Asp200 in mouse Trex1) 
are a small hydrophobic (Ile144) and a positively-charged (Arg264) residue, respectively. 
Furthermore, the hydrophilic residue (His195 in mouse Trex1) involved in orienting the attacking 
water molecule is Gly259 in Exu. These alterations prevent metal ion coordination and hydrolysis 
as Arg264 interacts with Asp39 and Asp41; this renders Exu a pseudonuclease (Fig. 2; 
Supplementary Fig. 4). Consequently, we refer to this domain as EXO-like. The large non-
conserved insertion at loop1 makes aligning primary sequences of Exu to other EXO proteins 
difficult, which is perhaps why we and others could not rule out Exu exonuclease activity based 
on primary sequence alone31.  
 
Exu forms a tight dimer via a finger-like β-hairpin loop  
The extensive Exu dimer interface is made up of two separate regions with 2770 Å2 of buried 
surface area from each monomer (16.8 % of monomer surface) (Fig. 3).  
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Dimerization is primarily mediated by the EXO-like domain, contributing 66% of the buried 
surface area (Fig. 3). In particular, a symmetrical interaction of the Exu-specific β-hairpin 
insertion in the EXO-like domain mediates dimer association. The inner surfaces of the β-hairpin 
loops face each other in an anti-parallel fashion and are bolstered by the helices on one side of the 
 β-sheet (Fig. 1, 3). Contacts of the SAM-like domain to the EXO-like domain through the outer 
surface of the hairpin consolidate the interaction across the dimer (Fig. 3a). The 
homodimerization surfaces of Exu are distinct from those observed in other exonuclease dimers 
such as Trex1 or RNaseT (Fig. 2a-b; Supplementary Fig. 3a).  
 
Conserved residues at the dimer interface stabilize the assembly mainly through hydrophobic 
interactions, hydrogen bonds and van der Waals contacts. In particular Arg92, conserved in all 
arthropods (Supplementary Fig. 1), forms a guanidinium π-stacked interaction with the 
symmetry-related Arg92 at the center of the interface (Fig. 3b; Supplementary Fig. 4). This 
interaction is stabilized by a hydrogen bond interaction with Asn72 and hydrophobic interactions 
with conserved Met68 and Met71 (Fig. 3b). Conserved Tyr70 and Tyr155 side chains in both 
monomers form a π-π interaction with each other (Fig. 3d). This interaction is consolidated by 
hydrogen bonding of Lys113 side chain to the backbone of Lys154.  
A single point mutation, R92A, and a double mutant, M68A Y70A, are sufficient to convert the 
protein to a monomer in solution as demonstrated by multi-angle laser light scattering (MALLS) 
experiments coupled to size exclusion chromatography (SEC) (Fig. 3e). Wild-type (wt) Exu 
dimers elute as a monodisperse peak in SEC in the presence of 300 mM NaCl, indicating that the 
dimer is salt resistant and stable in solution, consistent with its hydrophobic character (Fig. 3e). 
 
Exu is an RNA-binding protein  
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Co-localization studies in vivo and cross-linking experiments of cell lysates in vitro suggested 
that Exu associates with bcd mRNA25,34. Analysis of the charge distribution on the dimer surface 
reveals a high prevalence of positive electrostatic potential (Fig. 4a-b), consistent with nucleic 
acid binding. The positively-charged residues are grouped in two regions: a large surface on top 
of the dimer, spanning both monomers (Fig. 4a) and extending on the side of the EXO-like 
domain, and a smaller region at the bottom surface of the SAM-like domain (Fig. 4b). This 
surface charge distribution mirrors the distribution of conserved residues, underscoring their 
functional importance (Fig. 4c-d). 
SEC experiments of Exu alone and in complex with nucleic acids show that Exu forms a stable 
complex with ssRNA (Fig. 5a). Analysis of SEC-purified Exu in complex with (U)20 by UV-
cross-linking combined with mass-spectrometry (MS)38 revealed a pattern of cross-linked sites 
broadly corresponding to the conserved, positively-charged surfaces of Exu. Many	 of	 the 
identified residues are basic and hydrophobic and are found on both the EXO-like domain and the 
SAM-like domain (Fig. 4-5; Supplementary Table 1).  
Technical issues prevented the use of EMSA and ITC to assess Exu RNA binding affinities. We 
used fluorescence anisotropy (FA) to measure the affinity of RNA binding interactions. The 
affinity of wt Exu for (U)20 ssRNA is in the sub-micromolar range (94±22 nM) (Fig. 5d, f). 
Exu406 binds RNA with a somewhat reduced affinity compared to full-length protein (226±30 
nM) (Fig. 5d, f). This is consistent with the cross-linking of residues in the CTR 
(Supplementary Table 1); these residues are not conserved nor embedded in any recognizable 
motif (Supplementary Fig. 1). Removal of the SAM-like domain (Exu333), however, while not 
affecting dimerization (Fig. 5i), reduces the affinity of Exu for the RNA by almost 50-fold 
(4250±192 nM) (Fig. 5d, f). As the SAM-like domain is unstable in isolation and could not be 
purified, no direct affinity measurements could be made. 
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A known exu loss-of-function allele (exuPJ42 or exu1) bears an R339S mutation at a conserved 
arginine in the SAM-like domain39 (Supplementary Fig. 1). This substitution, and all others 
discussed below, does not impair protein folding (Supplementary Fig. 5e). However, it causes a 
small, reproducible decrease in RNA-binding affinity (Fig. 5e-f). Affinity is further decreased by 
a substitution with a more electronegative residue (R339E) (Supplementary Fig. 5c-d) and an 
additional point mutation at a cross-linked residue on the SAM-like domain (R339E R325E) 
(Fig. 5e-f). This is consistent with MS data that identified a UV-induced cross-link of Arg339 to 
(U)20 RNA (Fig. 5c).  
The SAM-like domain of Exu is structurally related to the SAM-like domain fold, including the 
CTD domains of bacterial RNA polymerases and the SAM domains of transcription regulators. 
Both superfamilies function in protein-protein and protein-nucleic acid interactions. A structure 
of Vts1 (the yeast ortholog of Smaug), a SAM domain-containing protein, in complex with an 
RNA hairpin suggested residues that might be involved in RNA binding in Exu. Point mutations 
to equivalent residues in Exu had no marked effect on RNA binding, showing that the RNA 
binding surface of Exu SAM-like domain differs from that of Vts1 (Supplementary Fig. 5). 
Moreover, other SAM-like domains lack the region where Arg339 resides. Therefore, Exu has 
unique RNA-binding features not observed in related structures (Supplementary Fig. 2).  
In addition, mutants of cross-linked and conserved residues on the EXO domain (R84E K95E 
R141E) display reduced affinity for the RNA (Fig. 5e-f). Therefore, RNA binding is mediated by 
both domains of Exu, including a contribution from Arg339 on the SAM-like domain. 
We characterized length requirements for ssRNA binding to Exu. A (U)8 sequence binds with 
low affinity, whereas increasing the RNA length to 30 and 50 nt leads to a considerable increase 
in binding affinity without inducing Exu multimerization (Supplementary Fig. 5f-g; 6), 
indicating the engagement of additional contacts on Exu.  
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Taken together, the in vitro binding and cross-linking MS data suggest that Exu might bind RNA 
directly in vivo.  
 
Exu dimer discriminates RNA secondary structure elements 
To further characterize Exu nucleic acid binding, we measured binding affinities to 20 nt 
oligomers of different sequence composition (Fig. 6) by FA. Exu binds to (U)20, (UC)10, ssRNA 
and ssDNA of mixed sequence with a similar affinity. While it is unclear whether ssDNA is a 
biologically relevant substrate, this observation is consistent with the surface properties of Exu 
(Fig. 4); that Exu binds weakly to dsDNA supports its cytoplasmic localization and function25 
(Supplementary Fig. 7). Exu has 6-fold lower affinity for (UA)10 and 7-fold higher affinity for 
(UG)10 as compared to (U)20 (Fig. 6a-d). While these differences in affinity may reflect a linear 
sequence preference, both UA- and UG-repeated oligomers are predicted to fold into secondary 
structures (Supplementary Fig. 6a), suggesting that Exu may bind preferentially to structured 
RNA. 
 Indeed, the 3'UTR of bcd is highly structured and subdivided into functional domains40,41 (Figure 
6e). One domain, which includes stem loops IV and V, is sufficient to recapitulate early steps of 
bcd localization42,43. A sub-region, stem loop Vb (overlapping with the bcd localization element 
1, BLE1), is essential for localization44. Perturbation of this region affects localization at a similar 
step as Exu requirement, consistent with a functional interaction44,34,43. 
As Exu has preferential binding for structured RNA sequences in vitro and is thought to associate 
with bcd mRNA in vivo, we measured Exu binding to the bcd-Vb element. Exu binds bcd-Vb 
with high affinity, 15±4 nM (Fig. 5-6). An antisense oligo, that retains similar secondary 
structure, binds with similar affinity to Exu (Fig. 6; Supplementary Fig. 6a), indicating that 
RNA conformation rather than primary sequence may be required in bcd BLE1 recognition. A 
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perfect dsRNA probe and the short ssRNA (U)8, which are similar lengths to the bcd-Vb stem 
and loop respectively, bind poorly to Exu, indicating that both elements are important for the 
recognition (Fig. 6; Supplementary Fig. 5). The binding is selective, as the localization signal 
on K10 mRNA (K10 transport/localization element, TLS), recognized by Egalitarian (Egl), 
another EXO-containing protein, binds 6-fold less strongly45,46	(Fig. 6).  
All Exu truncations and mutations to RNA cross-linked residues have decreased affinity for (U)20 
and for bcd-Vb compared with wt Exu, suggesting an overlap of binding surfaces on Exu (Fig. 5, 
6). However, two independent dimerization mutants (M68A Y70A and R92A) bind bcd-Vb RNA 
with reduced affinity of 7- and 20-fold, respectively. In contrast, the same dimerization mutants 
bind (U)20 RNA with a similar affinity as wt (110±6 and 34±4 nM, respectively) (Fig. 6f-h), 
showing that Exu homodimerization is specifically required for high affinity binding of bcd-Vb. 
Moreover, static light scattering experiments coupled to SEC suggest a stoichiometry of two bcd-
Vb (or two (U)20) molecules per Exu dimer, while 50 nt ssRNA binds with 1:1 stoichiometry 
(Supplementary Fig. 6). 
These data suggest that Exu distinguishes RNA secondary structure elements required for bcd 
localization and that dimerization promotes binding to a physiological target.  
 
Exu SAM-like domain and dimerization are required in vivo 
To gain further insights into Exu function we set up a structure-guided genetic rescue assay in 
vivo. We modified a genomic fragment containing the Exu gene25 to express an N-terminally 
Venus-tagged Exu at physiological levels. The constructs, encoding wt, mutant or truncated Exu 
proteins, were injected to generate transgenic flies and recombined into a landing site (attP) on 
the same position on chromosome 2, in a background lacking a 329 Kb genomic stretch on 
chromosome 2R encompassing the exu gene (Df(2R)exu1, here Df). In the rescue experiment, 
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these transgenic lines were crossed to flies heterozygous for a known exu-null allele, exuVL 47, to 
obtain progeny devoid of endogenous Exu and expressing the different Venus-tagged Exu 
constructs at similar levels (Fig. 7j). Early embryos were collected from these females and bcd 
mRNA was visualized by in situ hybridization.  
As expected, anterior localization of bcd is impaired in exu-null (Df/exuVL) early embryos, and 
this phenotype is fully rescued by Venus-Exu wt expression (FL; Fig. 7a-c). No defects in osk 
mRNA localization were observed (Supplementary Fig. 7), in agreement with previous 
studies22,29. A hybrid Exu protein, containing the loop1 substitution of the corresponding Bombyx 
mori sequence (Supplementary Fig. 1), retains full rescue activity (Fig. 7d). Similarly, an Exu 
protein mutated in the two residues conserved in other exonucleases (Fig. 2) is also fully 
competent for bcd localization (Fig. 7e), confirming that catalytic activity is not important for 
function. A corresponding mutation in other systems generated catalytically dead exonucleases 
and was used to show that exonuclease activity is not relevant for Egl function in vivo48. In 
contrast, mutations that disrupt Exu dimerization (Fig. 3) impair its ability to localize bcd 
mRNA, showing that the dimer is the functional unit of Exu in vivo (Fig. 7f-g). A construct 
including the structured domains, and lacking the CTR (Exu410), is sufficient to achieve proper 
bcd localization (Fig. 7h), indicating that our structure contains the essential functional features 
of Exu. In contrast, the EXO-like domain alone (Exu333) does not rescue bcd localization (Fig. 
7i), highlighting the functional importance of the SAM-like domain. A point mutation in this 
domain (R339S; Fig. 5c) also abolishes Exu function39.  
Exu has been shown to co-localize with bcd mRNA throughout early and mid-oogenesis15,25,39. 
We therefore examined the localization of our Venus-tagged Exu constructs at different stages of 
egg development (Supplementary Fig. 7). Venus-Exu FL is transported into the oocyte in pre-
vitellogenic egg chambers, concentrates at both anterior and posterior poles of the oocyte at stage 
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8-10 and is enriched in cytoplasmic foci in the nurse cells, consistent with previous reports25,39. 
Most of the analyzed constructs did not show obvious defects in Exu distribution 
(Supplementary Fig. 7). However, Exu333 failed to localize anteriorly in more than half of the 
examined oocytes (Supplementary Fig. 7). This correlates with the severe loss in RNA-binding 
affinity observed in vitro (Fig. 5). 
 
Discussion 
Exu is a pseudonuclease 
Our structure shows that Exu is a homodimeric multidomain protein consisting of an EXO-like 
domain coupled to a SAM-like domain.  
The presence of an EXO domain in a protein involved in RNA metabolism generally implies a 
functional role in RNA degradation. However, the structural and in vivo rescue analyses reveal 
that the EXO-like domain lacks a classical exonucleolytic active site and that mutation of 
residues conserved between Exu and active exonucleases has no appreciable impact on function.  
Instead, the EXO-like domain provides a different essential function for Exu, that of 
homodimerization. Exu monomers interact via conserved, hydrophobic and electropositive 
surfaces, suggesting that the dimer acts as a unitary structural and functional platform. Structure-
based mutants that prevent dimer formation are not functional in vivo, showing that Exu 
homodimerization is essential for bcd mRNA localization. 
 
Exu is an RNA-binding protein 
Our cross-linking MS and in vitro binding studies show that Exu is an RNA binding protein and 
that RNA binding residues lie within conserved, electropositive regions, suggesting a path of the 
bound RNA on the surface. Combining these studies with structure-guided mutations, we show 
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that both the EXO-like and SAM-like domains contribute to RNA binding. The dramatic 
reduction in RNA binding affinity on removal of the SAM-like domain highlights its major 
contribution to RNA binding, either alone or as a composite surface with the EXO-like domain. 
An Exu mutant lacking the SAM-like domain dimerizes in vitro but is non-functional in vivo.  
A single point mutation in the SAM-like domain, present in a previously described exu allele 
(R339S), impairs bcd localization39. This residue directly cross-links to RNA and its mutation 
consistently reduces RNA binding by 2-fold in vitro. While it is possible that this reduction 
would account for the loss-of-function phenotype in vivo, we cannot rule out that interactors apart 
from bcd mRNA are affected by this mutation. 
 
Exu discriminates secondary structure elements and functions as a dimer in vivo  
Here we show direct, high affinity binding of Exu to the bcd 3'UTR localization signal, BLE1, in 
agreement with data in flies showing that Exu and BLE1 are required in early stages of bcd 
localization44,34,43. The low affinity of Exu for an unrelated mRNA localization signal further 
implies that Exu-BLE1 recognition is specific, although additional factors might be involved. 
We also observe that Exu binds ssRNA, albeit with lower affinity, and that Exu binds 
preferentially particular sequences. Whether these sequences are recognized directly or have 
some intrinsic propensity to form secondary structures requires further investigation. In light of 
our findings that Exu has high affinity for the bcd-Vb element, the latter explanation seems more 
likely. However, we observe that long ssRNAs can also associate with Exu with high affinity. 
This might reflect an additional role of Exu in ssRNA packaging in the context of RNP transport 
particle formation. This mode of binding could be exploited by other RNAs that lack a structured 
signal (Fig. 7k). 
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Monomeric Exu mutants bind short RNA sequences with similar affinity to wild-type dimers but 
are specifically impaired in bcd-Vb stem loop recognition and are not functional in vivo. Our 
observations that RNA binding extends across both Exu monomers (from cross-linking and MS) 
and that Exu dimers likely bind two molecules of bcd-Vb RNA supports a role of Exu as a 
unitary platform for RNA binding. Our in vivo data show that RNA binding, like dimerization, is 
essential and these activities of Exu are coupled. 
 
Further studies are required to determine other physiological RNA targets of Exu, to characterize 
RNA binding and to explore its connection to the localization machinery. 
 
Evolution of Exu 
From sequence analysis, we found Exu homologs where conserved catalytic residues are retained 
in some lophotrocozoans (molluscs) and vertebrate sequences, indicating that these are active 
exonucleases (Supplementary Fig. 1). This suggests that Exu evolved from active exonucleases 
and lost its catalytic activity along the arthropod stem lineage. Other EXO domain proteins have 
been shown to bind RNA45,49,50. In particular, Maelstrom was recently shown to lack canonical 
EXO activity and features a Zn2+-binding insertion that plays a functional role in RNA binding 
and the piRNA pathway49,51. Furthermore, in the Drosophila mRNA localization pathway, Egl is 
predicted to contain an EXO domain. Egl function in dynein-dependent transport of localized 
mRNAs does not require an intact catalytic site45,48,52. Therefore, the loss of EXO activity and 
acquisition of RNA-binding function appear to have occurred independently in distantly related 
families of EXO-containing proteins. 
The presence of a SAM-like domain C-terminal to the EXO-like domain is unique to arthropods, 
suggesting that loss of the catalytic site coincided with recruitment of a SAM-like domain. We 
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also found that the β-hairpin loop that mediates dimerization in Drosophila Exu is conserved in 
arthropods but not outside arthropods. In Exu evolution as an RNA binding scaffold, we can 
identify three steps: loss of canonical EXO catalytic activity, acquisition of a SAM-like domain 
and insertion of a loop to mediate dimerization. Despite bcd being present only in high 
dipterans53,54, all insect lineages appear to have a conserved, catalytically inactive Exu ortholog, 
suggesting a broader function in the regulation of RNA expression. 
 
 
Accession codes 
The coordinates and structure factors have been deposited in the Macromolecular Structure 
Database of European Bioinformatic Institute (EBI) with ID code 5L7Z and 5L80 for Exu333 and 
Exu406, respectively.  
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Figure 1 
Structure of Exu dimer and constructs used.  
a) Schematic representation of the architecture of the proteins used in this study. Solid and 
dashed boxes represent folded domains and loop1 region, respectively. Thin lines are regions 
predicted to be unstructured. The constructs used are indicated in gray.  
b-e) Structure of Exu333 (b-c) and Exu406 (d-e) homodimers in two views related by a 90° rotation 
about the horizontal axis with monomer A (red), monomer B (gray) and the linker helix (teal) 
shown as cartoons. Dotted lines represent loop connections that are not visible in the electron 
density. Highlighted in orange is loop1, substituted in Exu406 structure and not ordered in the 
Exu333 structure. The EXO-like domains form a continuous horizontal bar with the β-hairpin 
loops facing each other. c, e) Lateral view of the dimeric complex showing the interaction 
interface between the helices of the EXO-like domains. 
These and all other protein structure figures were generated using PyMOL 
(http://www.pymol.org).  
 
Figure 2 
The EXO-like domain of Exu lacks residues required for exonuclease activity.  
		 22	
a) Catalytic center of Trex1 (PDB: 2IOC35,36) bound to AMP in a post-hydrolytic state. An 
overview of the dimer assembly is displayed on the left; one of the monomers (dashed box) is 
enlarged on the right with a black box indicating the region enlarged in the representation below. 
D18, E20, D130 and D200 coordinate the two catalytic Mn2+ ions (purple spheres) (c). b) 
Putative catalytic center of Exu333, in a similar representation to (a) with the corresponding 
residues in the EXO-like domain of Exu labeled. Dimer assembly is displayed on the left, with 
Exu monomer A (in red) in the same orientation as Trex1 monomer A (dark gray, a). c-d) 
Detailed views of the catalytic site of Trex1 and Exu, respectively. Acidic residues that match the 
DEDD consensus in the putative active site of Exu are indicated with black arrowheads. 
 
Figure 3 
Conserved residues mediate Exu dimerization. 
a, c) View of the monomer-monomer interface. Exu is shown in the same orientation as in Fig. 
1d and 1e, respectively. Molecule B is rendered as a gray surface, with interacting residues 
highlighted in teal. The interaction site is boxed in black. b, d) Zoomed-in views of the 
dimerization interface (in the same orientation as in a and c, respectively). Residues mutated in e 
are indicated with red and pink arrowheads, respectively. e) SEC and calculated molecular weight 
(obtained from MALLS) of Exu wt and of two dimerization mutants. 
 
Figure 4 
Surface properties of the Exu dimer. 
Surface representation of Exu in the same orientation as in Fig. 1d (a, c) and rotated 180º along 
the x axis (b, d). a-b) The surface is colored according to electrostatic potential with positively 
charged residues in blue. c-d) Exu surface rendering coloured according to conservation with a 
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gradient from white to green indicating increasingly conserved residues. Conservation scores 
were calculated from the arthropod sequences included in the multiple sequence alignment shown 
in Supplementary Fig. 1, using ConSurf55. The surface representations were generated from the 
coordinates of molecule A with all the side chains modelled and duplicated using the dimer 
symmetry. 
 
Figure 5 
Multiple residues on Exu surface are involved in RNA binding. 
a) SEC profiles of purified Exu wt (left), of Exu wt pre-incubated with (U)20 RNA (middle) and 
of (U)20 RNA alone (right). The position of the peak containing the free RNA is indicated by a 
dotted line and the elution volume of Exu wt by a gray line. 
b, c) Surface rendering of the Exu homodimer with the monomers in two shades of gray. The 
surface representations were generated as in Fig. 4, and in the same orientation as in Fig. 1d (b) 
or rotated 180º along the x axis (c). Residues UV-cross-linked to the RNA and identified by MS 
are highlighted in red and labeled. 
d-h) Kd values determined by FA. A constant amount of 5'-fluorescein labelled (U)20 (d-f) or bcd-
Vb hairpin (f-h) was incubated with increasing concentrations of the indicated recombinantly 
purified Exu constructs. The FA data were fitted to the Hill equation to obtain the dissociation 
constants (Kd); mean Kd and standard deviation are reported in table (f). Data are from three 
independent experiments, apart from R325E R339E + (U)20 (four); Exu333 and R339S + (U)20 
(five); Exu wt + (U)20 (nine), Exu wt + bcd-Vb (fifteen independent experiments). d-e, g-h) Data 
from representative FA measurements, with the best fit plotted as a solid line. i) SEC and 
calculated molecular weight (obtained from MALLS) of Exu333.	
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Figure 6 
Specificity of Exu binding to the RNA. 
a-d, f-h) Kd values determined by FA. A constant amount of 5'-fluorescein labeled 
oligonucleotide of the indicated sequence (c, h) was incubated with increasing concentrations of 
recombinantly purified Exu wt (a-d) or mutants (f-h). The FA data were fitted to the Hill 
equation to obtain the dissociation constants (Kd); mean Kd and standard deviation are reported in 
tables (c, h). Data are from three independent experiments, apart from Exu wt + (UA)10, ssDNA 
and K10 TLS (four); Exu wt + bcd-Vb antisense (five); Exu wt + (U)20 (nine), Exu wt + bcd-Vb 
(fifteen independent experiments). a-b, f-g) Data from representative FA measurements, with the 
best fit plotted as a solid line. d) Column graph of the data in table (c), plotting mean Kd (bars), 
standard deviation (black lines) and Kd values obtained for each measurement (gray dots). 
Numbers above the bars indicate the number of independent experiments performed. The dotted 
line is drawn at the mean Kd of Exu for bcd-Vb RNA (red bar). e) Schematic representation of 
bcd 3'UTR secondary structure, as described41. The BLE1 is highlighted in red and the bcd-Vb 
hairpin used in the FA measurements is boxed. 
 
Figure 7 
Drosophila phenotypes and bicoid localization. 
a-i) bcd in situ hybridizations of Drosophila early embryos (0-2 h). Numbers at the top right 
corner indicate the number of embryos displaying the illustrated phenotype vs the total number of 
embryos examined. The genotype of the analyzed embryos is reported at the bottom right of each 
image. All alleles are in trans-heterozygous combination with exuVL: a) wt; b) exu deficiency 
Df(2R)exu1 (Df); c-i) embryos expressing Venus-Exu transgenic constructs: c) full length (FL); 
d) loop1 sequence substituted with the corresponding residues from Bombyx mori (LDADS; see 
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also Supplementary Fig. 1); e) putative catalytic site mutant (D39A D41A); f-g) two 
dimerization mutants (M68A Y70A and R92A); h-i) C-terminal truncations containing both 
EXO-like and SAM-like domain (Exu410) or EXO-like domain alone (Exu333). Scale bar: 50 µm. 
j) Western Blot showing the expression levels of endogenous Exu (in exuVL heterozygous flies) 
and of the different transgenic Venus-Exu constructs (as in c-i) in ovaries. The blot was revealed 
with anti-GFP (top panel) and anti-Exu (middle panel) antibodies; anti-α-tubulin (bottom panel) 
was used as a loading control. Original images of the blots can be found in Supplementary Data 
Set 1. 
k) Proposed model of Exu RNA binding. 
 
Table 1 
Data collection and refinement statistics of the crystal structures of Exu333 and of Exu406. 
 
 Native Exu333 SeMet Exu333 Exu406 
Data collection    
Space group P6122 P6122 P21 
Cell dimensions      
    a, b, c (Å) 79.9, 79.9, 237.3 79.8, 79.8, 238.2 79.5, 66.6, 81.3 
    α, β, γ  (°) 90, 90, 120 90, 90, 120 90, 90, 113.6 
  Peak Inflection  
Wavelength 1.000 0.980 1.040 1.000 
Resolution (Å) 50-2.37 (2.47-2.37) 50-2.5 (3.00-2.5) 50-3.0 (3.3-3.0) 50-2.8 (2.9-2.8) 
Rsym or Rmerge  0.085 (0.972) 0.124 (0.693) 0.142 (0.653) 0.078 (1.045) 
I / σI 23.98 (3.2) 26.5 (7.3) 22.3 (6.2) 19.4 (2.2) 
Completeness (%) 100 (100) 100 (100) 100 (100) 99.5 (99.2) 
Redundancy 19.0 (19.6) 41.8 (42.0) 20.8 (20.1) 6.7 (6.6) 
     
Refinement     
Resolution (Å) 40-2.37   47.3-2.8 
No. reflections 18142   18391 
Rwork / Rfree 20.4/22.3   25.2/27.6 
No. atoms 3610   8456 
    Protein 3543   8445 
    Water 67   11 
B-factors (A∧2) 
   Protein 
 
   Water 
 
65.5 
70.2 
 
60.9 
  80.7 
Chain A 76.7 
Chain B 99.5 
66.0 
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R.m.s deviations     
    Bond lengths (Å) 0.002   0.003 
    Bond angles (°) 0.468   0.658 
One native crystal for each construct and one SeMet crystal were used for data collection. Values in parentheses are 
for the highest-resolution shell. 
 
 
 
 
Online Methods 
Protein expression and purification 
Exu from Drosophila melanogaster was cloned in a pET-MCN vector, derived from the pET 
Novagen series56. All Exu constructs were cloned in-frame with an N-terminal glutatione S-
transferase (GST) tag; Exu wt was also cloned in-frame with a hexahistidine (His) tag. The 
protein was expressed in E. coli BL21 StarTM (Life technologies) cells in auto-inducing medium57, 
overnight at 20°C. GST-tagged constructs were affinity-purified on glutathione resin in lysis 
buffer (20 mM Tris-HCl pH 7.5 at 4°C, 1.2 M NaCl, 10% glycerol) containing 1 mM DTT. After 
washing 3 times in buffer A (20 mM Tris-HCl pH 7.5 at 4°C, 300 mM NaCl, 10% glycerol, 1 
mM DTT), the recombinant protein was eluted from the resin by incubating with TEV protease 
overnight at 4°C, in buffer A. His-tagged Exu wt was purified by cobalt affinity chromatography 
in lysis buffer containing 20 mM imidazole and 1 mM beta-mercaptoethanol (β-me), and eluted 
with a gradient to 250 mM imidazole. The His-tag was subsequently removed by dialysis in the 
presence of TEV protease overnight at 4°C, in buffer A. In both cases, the protein was applied to 
a heparin resin, eluted with a gradient to 1M NaCl, and further purified by SEC on a HiLoad 
16/600 Superdex 200 pg column (GE Healthcare), in buffer A. Mutants and truncations were 
generated by site-directed mutagenesis from the GST-tagged construct, and purified as described 
above. 
		 27	
To produce Exu333 selenomethionine (SeMet) labeled protein, the construct was expressed in an 
E. coli methionine auxotroph strain, DL41, in M9 medium and starved before addition of SeMet. 
The protein was purified as described above for the unmodified protein. 
 
Crystallization, data collection and analysis 
Crystals of Exu333 were obtained in 6% MPD, 0.05 M MES, pH 6.5 and grown at 4°C by vapor 
diffusion. For data collection, crystals were cryo-protected with mother liquor supplemented with 
gradual addition of glycerol up to 30-40% and flash frozen in liquid nitrogen. The crystals 
diffracted to 2.37 Å resolution, belong to the space group P6122 with cell dimensions of 
a=b=79.9 Å, c=273.3 Å, α=β=90°, γ=120° and contain one molecule in the ASU. Data were 
processed and scaled using XDS58. The structure was solved by SAD phasing of the SeMet 
substituted Exu333. 7 Selenium sites and initial phases were obtained with SHELX59. Refinement 
was carried out using iterative cycles of model building in COOT60 and restrained refinement in 
PHENIX61. 
Crystals of Exu406 grew in 250 mM sodium malonate, 18% PEG 1000, 50 mM MES, pH 6 at 4°C 
by vapor diffusion and were snap frozen as above. The crystals diffracted to 2.80 Å and belonged 
to space group P21 with cell dimensions of a=79.5 Å, b=66.6 Å, c=81.3 Å and α=β=90°, 
γ=113.6°. The structure was solved by MR using PHASER62 and the Exu333 structure as a search 
model. Iterative cycles of model building and restrained refinement were carried out in COOT 
and PHENIX60,61. For both native datasets, the resolution cutoff was chosen to at least include 
I/σ>2.  
All diffraction data were collected at the PXII beamline of the Swiss Light Source (Villigen, 
Switzerland). 100% of the residues in each structure fall within the allowed regions of the 
Ramachandran plot. 
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We refer to the higher resolution structure of Exu333 for molecular details and to the structure of 
Exu406 for overviews. Unless stated otherwise, we refer to molecule A throughout the manuscript. 
Residues are numbered according to Exu wt sequence.  
 
Laser light scattering 
For MALLS, purified Exu wt and two dimerization mutants (M68A Y70A and R92A) were 
loaded onto a Superdex 200 10/300 GL column (GE Healthcare) connected to a miniDAWN 
TREOS MALLS detector and Optilab rEX differential refractometer (Wyatt Technologies). Each 
run was performed with 0.5 mg of protein, in buffer A, at 12°C. Molecular weight calculations 
were performed using ASTRA software (Wyatt Technologies). 
For Right-Angle Light Scattering (RALS), samples were loaded onto a Superdex 200 5/150 
column (GE Healthcare) connected to a TDA302 detector array (Viscotek), in buffer H (20 mM 
Hepes pH 7.5, 300 mM NaCl and 10% glycerol), at room temperature (RT, 21-23ºC). Runs were 
performed with 10 mg/ml of purified Exu wt alone, or 1 mg/ml of Exu wt pre-incubated for 10’ at 
RT with 2.5 molar excess of 5'‐6‐carboxy‐fluorescein (6‐FAM)‐labeled RNA. Sample volume 
was 20 μl. Data were analyzed using OmniSEC 4.5 software. 
 
Analytical size exclusion chromatography 
Exu (12.5 nmol) was incubated alone or with a 1.2 molar excess of RNA in buffer A, overnight at 
4°C. The samples were analyzed on a Superdex 200 10/300 GL column (GE Healthcare), in 
buffer A, monitoring UV absorbance at 280 and 260 nm.  
 
Fluorescence anisotropy 
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FA measurements were performed with 5'-6-FAM-labeled RNA at RT on an Infinite F200 plate 
reader (Tecan). The RNA, at a concentration of 10 nM, was incubated with different 
concentrations of purified Exu wt or mutants, in buffer H. The final reaction volume was 50 μl. 
Each titration point was measured three times, with an integration time of 40 μs, using 485 nm 
and 535 nm as excitation and emission wavelength, respectively. The data were analyzed by 
nonlinear regression fitting using the Prism 6 software (GraphPad). 
Nucleic acid sequences are as follows (5' to 3'): AGGCAGUUUCUGGUACUCAG (50% GC 
RNA; 50% GC DNA has the same sequence; perfectly complementary RNA or DNA unlabeled 
oligonucleotides were used to generate dsRNA or dsDNA, 
respectively); CCCAAAAUGAAAAAUGUUUCUCUUGGGCGUAAUCUCAUACAAUGAUU
ACCCUUAAAGAUCGAACAUUUAAACAAUAAUAUUUGGG (bcd-
Vb); CGCUUGAUUGUAUUUUUAAAUUAAUUCUUAAAAACUACAAAUUAAGC (K10 
TLS). 
 
Circular Dichroism (CD) 
CD spectra were recorded on a Jasco J-810 spectropolarimeter, at 20ºC. Measurements were 
performed using 200 μl of recombinantly purified Exu (wt or mutants), at a concentration of 0.2 
mg/ml, in buffer A. Each spectrum was recorded 5 times, and averaged. 
 
Mass spectrometry 
UV-induced protein-RNA cross-linking and enrichment of cross-linked peptides. UV-cross-
linking and enrichment of cross-linked peptides was performed according to established 
protocols38. Briefly, Exu was incubated with a 1.2 molar excess of (U)20 RNA in buffer A’ (20 
mM Tris-HCl pH 7.5 at 4°C, 300 mM NaCl), overnight at 4°C, and analyzed on a HiLoad 16/600 
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Superdex 200 pg column (GE Healthcare), in buffer A’. The peak corresponding to the Exu:RNA 
complex was collected and the concentration adjusted to 8.6 μM. The sample (100 μl) was 
transferred to black polypropylene microplates (Greiner Bio-One) and irradiated at 254 nm for 10 
min; an equal volume of sample was kept as non-irradiated control. After ethanol precipitation, 
the samples were denatured in 4 M urea and 50 mM Tris-HCl, pH 7.9, diluted to 1 M urea in the 
same buffer and digested for 2 h at 52°C with 5 μg RNase A (Ambion, Applied Biosystems). 
After RNA digestion, proteolysis with trypsin (Promega) was performed overnight at 37°C with 
an enzyme to protein ratio of 1:20. The sample was desalted on an in-house–prepared C18 (Dr. 
Maisch GmbH) column, and the cross-linked peptides were enriched on an in-house–prepared 
TiO2 (GL Sciences) column as previously described38. The samples were dried and then 
resuspended in 10 μl sample solvent (5% v/v ACN and 1% v/v Formic Acid) for MS analysis. 
Nano–liquid chromatography and MS analysis. 8 μL of the above sample was injected onto a 
nano–liquid chromatography system (EASY nLC II, Thermo Scientific) including a C18 trapping 
column of length ~4 cm and inner diameter 100 μm, in line with a C18 analytical column of 
length ~10 cm and inner diameter 50 μm (both packed in house; C18 AQ 120 Å 5 μm trapping 
column or 3 µm analytical column). Analytes were loaded on the trapping column at a maximum 
pressure of 300 bar in buffer AF (0.1% v/v Formic Acid), washed with 25 µl buffer and 
subsequently eluted and separated on the analytical column with a gradient of 5–35% buffer BF 
(95% v/v acetonitrile and 0.1% v/v Formic Acid) with an elution time of 37 min (0.77%/min) and 
a flow rate of 300 nL/min. Online ESI-MS was performed with an Q Exactive instrument 
(Thermo Scientific), operated in data-dependent mode with a TOP10 method. MS scans were 
recorded in the m/z range of 350–1,600 at a resolution of 70,000 FWHM and for subsequent 
MS/MS the top ten most-intense ions were selected. Both precursor ions as well as fragment ions 
were scanned in the Orbitrap. Fragment ions were generated by higher-energy collision 
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dissociation (HCD) activation (normalized collision energy = 25) and recorded from m/z = 100 
with a resolution of 7500 FWHM.  
Database search with cross-linking MS. Data analysis was performed as previously described38. 
Briefly, raw data was converted into the open mzML format63 with msconvert (part of 
ProteoWizard64) and processed with OpenMS65,66 with OMSSA67 as database search engine. The 
data from the cross-linking experiment and the non-irradiated control was centroided and aligned 
to correct for retention time shifts. A first search against a target-decoy database containing the 
sequences of full-length Exu lacking loop1 (as distributed with MaxQuant68) identified confident 
peptide-spectrum-matches (FDR 1%) that were excluded from further analysis. Next, fragment 
spectra were filtered from the cross-linking data if the precursor was observed in the non-
irradiated control at comparable intensity (fold change < 2) or if it originated from a small RNA 
oligonucleotide (M < 1750 Da and fractional mass < 0.2). For all remaining precursors, variants 
were generated by subtracting calculated RNA masses of one to four uridines with several RNA 
modifications (–H2O, –HPO3, –H3PO4, –H2O + 152, –HPO3 + 152, –H3PO4 + 152.). The fragment 
spectra were searched with the original precursor and all its variants against a database containing 
full-length Exu wt and LDADS (see Supplementary Fig. 1). All reported cross-links were 
validated by close manual inspection of the fragment spectra. 
 
Fly stocks 
The following fly stocks were used: OregonR (wild-type), Df(2R)exu1, cn1 bw1 sp1 / CyO, P{hs-
hid}4 / exuVL, cn1 bw1 / CyO, P{hs-hid}4 / exuQR, cn1 bw1 / CyO, P{hs-hid}447,69. For the transgenes 
a genomic fragment containing the exu gene25 was modified to yield N-terminal Venus-
StrepTagII fusions of wt, mutant or truncated Exu proteins. The constructs were cloned into the 
pUAST-attB vector via BamHI, thereby deleting the UAS-sites and the SV40 poly(A) signal. The 
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purified vectors were injected into embryos from a recombinant stock with the genotype: y1 
M{vas-int.Dm}ZH-2A w*; M{3xP3-RFP.attP}ZH-22A cn1 Df(2R)exu1 bw1 sp1 / SM6a and 
transgenic flies were identified in the F1 generation by the presence of orange eyes. In the 
following generation the CyO, P{hs-hid}4 balancer chromosome was introduced into the stocks. 
Ovaries and embryos used for in situ hybridization, Western Blots and imaging were obtained 
from these transgenic flies crossed to exuVL, cn1 bw1 / CyO, P{hs-hid}4 flies, and selected against 
the presence of the balancer chromosome. 
 
In situ hybridization and antibody staining 
Ovary dissection was performed as described previously70. Ovaries were fixed in PBS containing 
0.2% Tween 20, 4% paraformaldehyde, and stained with rhodamine-phalloidin (Molecular 
Probes R415, 1:1000) for 20’ at RT. Samples were mounted in Fluoromount-G 
(SouthernBiotech), and imaged on an Olympus FluoView1000 confocal microscope using a 
UPLSAPO 60x oil objective (NA 1.35). Images were processed with ImageJ71. 
Early embryos were collected according to standard protocols72. For in situ hybridizations, full-
length bcd and osk anti-sense RNA probes were labeled with Digoxigenin-UTP (Roche) and 
detected with Alkaline Phosphatase-conjugated anti-digoxigenin antibody (Roche 11093274910, 
1:2000). Images were acquired on a Zeiss AxioImager Z.1 microscope, using a Plan-Apochromat 
10x objective (NA 0.45) and a differential interference contrast (DIC) condenser. 
The following antibodies were used for Western Blots: anti-GFP polyclonal antibody (Life 
Technologies A11122, 1:2000), anti-α-tubulin monoclonal antibody (Sigma T6074, 1:5000), 
anti-Exu serum (1:1000). The anti-Exu serum was developed in house in rabbits using purified 
Exu wt (see Fig. 7j for validation). Exu410 and Exu333 are poorly recognized by our anti-Exu 
polyclonal serum suggesting that the CTR of Exu is more immunogenic than the folded domains 
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of the protein. The C-terminally truncated constructs migrate as a single band, consistently with 
the absence of phosphorylation sites. 
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Supplementary Figure 1 
Alignment of Exu homologs. 
Sequences used to generate the alignment include: [Insecta, order Diptera] D. melanogaster (Dme), D. simulans, D. sechellia, D. 
yakuba, D. erecta, D. ananassae, D. virilis, D. mojavensis, D. willistoni, D. pseudoobscura pseudoobscura, D. persimilis, D. grimshawi, 
D. miranda, D. affinis, B. cucurbitae, B. dorsalis, C. capitata, M. domestica (Mdo), A. gambiae (Aga), A. sinensis, A. darlingi, C. 
quinquefasciatus, A. aegypti; [Lepidoptera] B. mori (Bmo), D. plexippus, P. aegeria; [Coleoptera] D. ponderosae, T. castaneum (Tca); 
[Phthiraptera] P. humanus corporis; [Isoptera] Z. nevadensis (Zne), M. rotundata; [Hymenoptera] B. terrestris, B. impatiens, A. mellifera 
(Ame), A. florea, N. vitripennis, M. demolitor (Mde), S. invicta (Sin), C. biroi, C. floridanus, A. echinatior, H. saltator; [Hemiptera] A. 
pisum (Api), D. citri, R. pedestris (Rpe); [Crustacea] D. pulex (Dpu); [Mollusca] C. gigas (Cgi); [Chordata] D. rerio (Dre). Numbering 
refers to the Dme sequence. Only the suborder Cyclorrapha (Diptera) has a Bicoid ( ) gene. 
The secondary structure of Dme Exu333 and Exu406 is schematized above the alignment (β-sheets: ; α-helices: ; residues not 
ordered in the structure are shown as dotted lines; gaps indicate regions for which no structural information is available). Residues 
involved in Dme Exu dimerization: ; residues confirmed by mutagenesis: ; conserved residues are highlighted in red. Non conserved 
loop1 is framed by a orange box; the corresponding residues in Bmo Exu (used to replace the loop in the Exu406 construct used for 
crystallization), are highlighted in the same color. Catalytic residues in the exonuclease domain: ; mutated residues: ; conserved 
catalytic residues are highlighted in blue. Residues cross-linked to RNA: ; Arg339: . Black arrows indicate the boundaries of the 
Exu333, Exu406 and Exu410 constructs. The phosphorylation sites identified in Dme Exu (Riechmann and Ephrussi, Development. 131, 
5897-5907, 2004) are marked by asterisks. The β-hairpin insertion is shaded in grey; the linker between the Exo-like and the SAM-like 
domains in light teal; the helices of the SAM-like domain in light red. The alignment was generated with MUSCLE (Edgar, Nucleic Acids 
Res. 32, 1792-1797, 2004), visualized with ESPript (Robert and Gouet, Nucleic Acids Res. 42, W320-W324, 2014) and edited in Adobe 
Illustrator. 
 
 
 
Supplementary Figure 2 
Structural homologs of Exu SAM-like domain. 
a) Cartoon representation of Exu406 (left) and of Exu SAM-like domain structure (aa 321-397; right). b) A structural similarity search in 
PDBeFold (Krissinel and Henrick, Acta Cryst. D60, 2256-2268, 2004) with Exu SAM-like domain outputs the sterile alpha motif (SAM), 
with Z-score = 4.4, and the C-terminal domain of RNA polimerase alpha, with Z-score = 4.2. c) Yeast Vts1p is a homolog of the 
Drosophila protein Smaug, and also contains a SAM domain which is involved in RNA binding (see also Supplementary Fig. 5). All 
structures in b) and c) belong to the SAM domain-like fold (SCOP 47768). Structural alignment was done with cealign in Pymol (v 
1.7.6.0). 
 
 
 
 
 
Supplementary Figure 3 
Comparison of DEDD exo- and pseudo-nucleases. 
a) Structure-based sequence alignment of the EXO and EXO-like domains of Drosophila Exu (Exu_Dm) and of structurally similar 3'-5' 
DEDD exonucleases, mouse Trex1 (Trex1_Mm) and E. coli RNaseT (RNaseT_Ec). Secondary structure elements are shown above 
the sequences, in red for Exu and in dark gray for Trex1. Conserved residues are highlighted in dark gray. Blue boxes indicate EXO 
signature motifs, while signature catalytic residues are marked in red. Brackets indicate protein-specific insertions that are hidden for 
clarity. The positions of Exu β-hairpin insertion, loop1 and linker are indicated. For each protein, residues involved in homodimerization 
are highlighted in light blue. 
b-e) Cartoon (left) and surface (middle and right) representation of the indicated protein structures. Exu333 (b) and Trex1 (d) are in the 
same orientation as in Fig. 2a, b. Residues in the (pseudo-)catalytic site are shown as sticks; ions (Zn2+ in (c) and Mn2+ in (d)) are 
represented as spheres. Protein-specific features are highlighted in red: linker helix and β-hairpin insertion in Exu (b); Zn2+ coordinating 
extension in Maelstrom (Mael) (c). Surface is colored according to the electrostatic charge, with the (pseudo)-catalytic site boxed in 
yellow. Structural alignment was done with cealign in Pymol (v 1.7.6.0). Scale of electrostatic charge distribution is the same for all 
domains (-5 to +5 kT/e). 
 
 
 
 
 
Supplementary Figure 4 
Quality of the electrondensity. 
Stereo view of the electrondensity of the 2Fo-DFc maps for Exu333 (a) and Exu406 (b) structures after refinement. The structures are 
shown in similar views as in Fig. 2e and Fig. 3b, respectively. Monomer A is colored red, monomer B gray, the electrondensity 
visualized as a teal mesh contoured at 1σ. Water molecules are represented as light blue spheres. 
 
 
 
Supplementary Figure 5 
Exu and Vts1p SAM domains use different surfaces for RNA binding. 
 
 
a-b) Surface rendering of electrostatic charges of Exu SAM-like (a) and yeast Vts1p (b; PDB 2B6G, chain A) domain structure (see also 
Supplementary Fig. 2). a) Exu residues cross-linking with RNA (Fig. 5) are underlined. b) Vts1p residues shown to interact directly 
with the RNA (Aviv et al., NSMB 13, 168-176, 2006; Johnson and Donaldson, NSMB 13, 177-178, 2006; Oberstrass et al., NSMB 13, 
160-167, 2006) are indicated. Structural alignment was done with cealign in Pymol (v 1.7.6.0). Scale of electrostatic charge distribution 
is the same for all domains (-5 to +5 kT/e). 
c-d, f-g) A constant amount of 5'-fluorescein labelled oligo was incubated with increasing concentrations of recombinantly purified Exu 
wt or mutant. The fluorescence anisotropy data were fitted to the Hill equation to obtain the dissociation constant (Kd); mean Kd and 
standard deviation from three independent experiments are reported in tables (d, g). c, f) Data from a representative fluorescence 
anisotropy measurement, with the best fit plotted as a solid line. c, d) FA measurements of SAM-like domain mutants with (U)20. f, g) 
Affinity of Exu for oligo(U) RNAs of increasing length. e) Circular Dichroism (CD) spectra of Exu wt and the indicated mutants. 
 
 
 
Supplementary Figure 6 
 
 
Exu can bind two RNA molecules. 
a) Oligonucleotides used in this study predicted to have a secondary structure, using the mFold server (Zuker, Nucleic Acids Res. 31, 
3406-3415, 2003). Numbers indicate the ΔG (in kcal/mol) at 22°C. 
b-e) SEC profiles of purified Exu alone (b) or pre-incubated with fluorescein-conjugated (U)20 (c), (U)50 (d) or bcd-Vb (e). The elution 
volume of the free RNA is marked by a dotted line. f-i) Static light scattering profiles of the samples in (b-e). For each plot, the 
calculated molecular weight (MW) at the peak is indicated in blue; the difference in molecular weight (Δ MW) between the Exu-RNA 
complex and Exu alone is indicated on the right, together with the MW of the corresponding fluorescein-conjugated oligonucleotide. 
RALS = Right Angle Light Scattering. 
 
 
 
Supplementary Figure 7 
Localization of Venus-tagged Exu transgenes. 
a-g) Fluorescence microscopy images of fixed Drosophila egg chambers at stage 5-6 (small box) or stage 9. The localization of Venus-
 
 
tagged Exu wt (a) and mutants (b-g) is shown in gray (left image); the merged images (right) show Venus-Exu in gray and Rhodamine-
Phalloidin in red. h) For each genotype, at least 20 egg chambers were scored for the presence (black) or absence (white) of the 
following characteristics: enrichment of Venus-tagged Exu in the oocyte at early stages (1st panel from left); enrichment in sponge 
bodies in the nurse cells at stage 9 (2nd panel); enrichment at the anterior pole of the oocyte at stage 9 (3rd panel); enrichment at the 
posterior pole of the oocyte at stage 9 (4th panel). The rightmost column schematizes the localization of bcd mRNA in early embryos of 
the corresponding genotype (as in Fig. 7). Red lines mark the lowest percentage of egg chambers having the indicated characteristic 
amongst the Exu constructs which rescue bcd mRNA localization. 
i-j) oskar (osk) in situ hybridization of Drosophila early embryos (0-2 h). Numbers at the top right corner indicate the number of embryos 
displaying the illustrated phenotype vs the total number of embryos examined. The genotype of each embryo is reported at the bottom 
of the image: i) wt; j) Df(2R)exu1/exuVL (Df). osk localization is not impaired in embryos lacking Exu. Scale bars: 50 µm. 
position peptide RNA cross-linked	aa
L47-R78 LMDEIVQLAAYTPTDHFEQYIMPYMNLNPAAR U L47-M48
L47-R78 LM(Oxidation)DEIVQLAAYTPTDHFEQYIM(Oxidation)PYM(Oxidation)NLNPAAR U-H2O P75-A76
H81-R92 HQVRVISIGFYR UU R84
V85-R92 VISIGFYR U-H2O F90
V85-K95 VISIGFYRMLK U Y91
M93-K101 MLKSMQTYK U K95
S96-K101 SMQTYK U Y100
S96-K101 SMQTYK UU M97
S105-K113 SKSEIAALK U -
A126-R141 AGPSSDGIVLIYHEER U Y137
A126-K142 AGPSSDGIVLIYHEERK U R141
K154-R160 KYGLLER U K154
S167-K176 SFANSINLAK U S167-F168
A177-K185 ASIGDANIK U -
A177-R190 ASIGDANIKNYSLR U K185
A177-R190 ASIGDANIKNYSLR UU	-H2O N183-I184
I195-R264 ILSLDADSLFDGNASVR U	-H2O F257
Q321-K333 QNSFRPVFLNYFK U R325
T334-R339 TTLYHR U	-H2O L336
T334-R339 TTLYHR U Y337
T334-R341 TTLYHRVR U R339
I347-K366 IVLAENGFDLNTLSAIWAEK U	-H2O -
N367-R380 NIEGLDIALQSIGR U	-H2O I373
N367-K382 NIEGLDIALQSIGRLK UU G379-R380
S383-K400 SKDKAELLELLDSYFDPK U Y396
T402-K409 TTVKPVVK U T402-T403
G410-R419 GNSNNNNNYR U Y418
D432-K451 DARPSSSPSASTEFGAGGDK U	-HPO3 F445
D432-K451 DARPSSSPSASTEFGAGGDK U	-H2O P435-S436
S454-K464 SVSSLPDSTTK U	-H2O -
T465-R472 TPSPNKPR UU	-HPO3 -
Q481-K491 QSLGATPNGLK U	-H2O L490
Supplementary Table 1. UV-cross-linking and MS results.
The first tab summarizes all unique cross-linked regions together with the
position and sequence of the cross-linked peptide, the composition of the cross-
linked RNA, and the position or range of the cross-linked amino acid(s). The
second tab lists all identified cross-links that include redundant information, i.e.,
the same peptide cross-linked to RNA of different length or with different
modifications, or the same RNA cross-linked to an unmodified and modified or
missed cleaved version of the same peptide. In addition, calculated values for
peptide, RNA and cross-link masses are listed together with experimental mass
values and mass errors.
position peptide RNA cross-linked	aa peptide RNA cross-link z m/z m/z	exp error	ppm
R46-R78 RLMDEIVQLAAYTPTDHFEQYIM(Oxidation)PYM(Oxidation)NLNPAAR U R46-D49 3942.8742 324.0359 4266.9101 4 1067.7353 1067.7347 -0.6
R46-R78 RLMDEIVQLAAYTPTDHFEQYIM(Oxidation)PYM(Oxidation)NLNPAAR UU - 3942.8742 630.0612 4572.9354 4 1144.2416 1144.2389 -2.4
L47-R78 LMDEIVQLAAYTPTDHFEQYIMPYMNLNPAAR U L47-M48 3754.7833 324.0359 4078.8192 3 1360.6142 1360.6142 0.0
L47-R78 LM(Oxidation)DEIVQLAAYTPTDHFEQYIMPYMNLNPAAR U - 3770.7782 324.0359 4094.8141 4 1024.7113 1024.7082 -3.0
L47-R78 LM(Oxidation)DEIVQLAAYTPTDHFEQYIMPYMNLNPAAR UU - 3770.7782 630.0612 4400.8394 3 1467.9543 1467.9580 2.6
L47-R78 LMDEIVQLAAYTPTDHFEQYIM(Oxidation)PYMNLNPAAR U L47-M48 3770.7783 324.0359 4094.8142 4 1024.7114 1024.7095 -1.8
L47-R78 LMDEIVQLAAYTPTDHFEQYIMPYM(Oxidation)NLNPAAR U L47-M48 3770.7783 324.0359 4094.8142 4 1024.7114 1024.7082 -3.1
L47-R78 LM(Oxidation)DEIVQLAAYTPTDHFEQYIMPYM(Oxidation)NLNPAAR U L47-M48 3786.7731 324.0359 4110.8090 4 1028.7101 1028.7106 0.5
L47-R78 LMDEIVQLAAYTPTDHFEQYIM(Oxidation)PYM(Oxidation)NLNPAAR U L47-M48 3786.7731 324.0359 4110.8090 3 1371.2775 1371.2764 -0.8
L47-R78 LM(Oxidation)DEIVQLAAYTPTDHFEQYIM(Oxidation)PYM(Oxidation)NLNPAAR U-H2O P75-A76 3802.7680 306.0253 4108.7933 4 1028.2061 1028.2069 0.8
L47-R78 LM(Oxidation)DEIVQLAAYTPTDHFEQYIM(Oxidation)PYM(Oxidation)NLNPAAR U - 3802.7680 324.0359 4126.8039 4 1032.7088 1032.7089 0.1
H81-R92 HQVRVISIGFYR UU R84 1473.8204 630.0612 2103.8816 3 702.3017 702.3012 -0.6
V85-R92 VISIGFYR U-H2O F90 953.5334 306.0253 1259.5587 2 630.7872 630.7868 -0.6
V85-R92 VISIGFYR U F90 953.5334 324.0359 1277.5693 2 639.7925 639.7914 -1.6
V85-R92 VISIGFYR UU	-H3PO4 G89-F90 953.5334 532.0843 1485.6177 2 743.8166 743.8160 -0.9
V85-R92 VISIGFYR UU	-HPO3 F90 953.5334 550.0948 1503.6282 2 752.8219 752.8214 -0.7
V85-R92 VISIGFYR UU	-H2O F90 953.5334 612.0506 1565.5840 2 783.7998 783.7990 -1.0
V85-R92 VISIGFYR UU F90 953.5334 630.0612 1583.5946 2 792.8051 792.8045 -0.7
V85-R92 VISIGFYR UUU	-HPO3 G89-F90 953.5334 856.1201 1809.6535 2 905.8346 905.8336 -1.1
V85-R92 VISIGFYR UUU	-H2O F90 953.5334 918.0759 1871.6093 2 936.8125 936.8114 -1.1
V85-R92 VISIGFYR UUU F90 953.5334 936.0865 1889.6199 2 945.8177 945.8162 -1.6
V85-K95 VISIGFYRMLK U Y91 1325.7529 324.0359 1649.7888 2 825.9022 825.9018 -0.5
V85-K95 VISIGFYRMLK UU Y91 1325.7529 630.0612 1955.8141 2 978.9148 978.9143 -0.5
V85-K95 VISIGFYRM(Oxidation)LK U Y91 1341.7478 324.0359 1665.7837 3 556.2690 556.2683 -1.3
V85-K95 VISIGFYRM(Oxidation)LK UU Y91 1341.7478 630.0612 1971.8090 3 658.2775 658.2761 -2.1
V85-K95 VISIGFYRM(Oxidation)LK UUU - 1341.7478 936.0865 2277.8343 3 760.2859 760.2855 -0.5
M93-K101 MLKSMQTYK U K95 1128.5671 324.0359 1452.6030 2 727.3093 727.3082 -1.5
M93-K101 MLKSMQTYK UU K95 1128.5671 630.0612 1758.6283 2 880.3219 880.3210 -1.1
M93-K101 MLKSMQTYK UUU - 1128.5671 936.0865 2064.6536 2 1033.3346 1033.3329 -1.6
M93-K101 M(Oxidation)LKSMQTYK UU K95 1144.5620 630.0612 1774.6232 2 888.3194 888.3172 -2.5
M93-K101 MLKSM(Oxidation)QTYK U K95 1144.5620 324.0359 1468.5979 2 735.3068 735.3072 0.6
M93-K101 MLKSM(Oxidation)QTYK UU - 1144.5620 630.0612 1774.6232 2 888.3194 888.3170 -2.7
S96-K101 SMQTYK U S96-M97 756.3476 324.0359 1080.3835 2 541.1996 541.1993 -0.5
S96-K101 SMQTYK U Y100 756.3476 324.0359 1080.3835 2 541.1996 541.1987 -1.6
S96-K101 SMQTYK UU M97 756.3476 630.0612 1386.4088 2 694.2122 694.2115 -1.0
S96-K101 SM(Oxidation)QTYK U-H2O Y100 772.3425 306.0253 1078.3678 2 540.1917 540.1907 -1.9
S96-K101 SM(Oxidation)QTYK U Y100 772.3425 324.0359 1096.3784 2 549.1970 549.1964 -1.1
S96-K104 SMQTYKIIK UU	-H2O - 1110.6107 612.0506 1722.6613 2 862.3385 862.3373 -1.3
S96-K104 SMQTYKIIK UU Y100 1110.6107 630.0612 1740.6719 2 871.3437 871.3448 1.2
S96-K104 SM(Oxidation)QTYKIIK UU Y100 1126.6056 630.0612 1756.6668 2 879.3412 879.3407 -0.5
S105-K113 SKSEIAALK U - 945.5494 324.0359 1269.5853 2 635.8005 635.7997 -1.2
S105-K113 SKSEIAALK UU - 945.5494 630.0612 1575.6106 2 788.8131 788.8134 0.4
T124-R141 TKAGPSSDGIVLIYHEER U - 1971.0061 324.0359 2295.0420 3 766.0218 766.0181 -4.8
A126-R141 AGPSSDGIVLIYHEER U Y137 1741.8634 324.0359 2065.8993 2 1033.9575 1033.9571 -0.3
A126-K142 AGPSSDGIVLIYHEERK U R141 1869.9584 324.0359 2193.9943 3 732.3392 732.3385 -1.0
A126-K142 AGPSSDGIVLIYHEERK UU R141 1869.9584 630.0612 2500.0196 3 834.3477 834.3475 -0.2
A126-K142 AGPSSDGIVLIYHEERK UUU R141 1869.9584 936.0865 2806.0449 3 936.3561 936.3558 -0.3
K154-R160 KYGLLER U K154 877.5021 324.0359 1201.5380 2 601.7768 601.7759 -1.5
K154-R160 KYGLLER UUU - 877.5021 936.0865 1813.5886 2 907.8021 907.8008 -1.4
S167-K176 SFANSINLAK U S167-F168 1063.5661 324.0359 1387.6020 2 694.8088 694.8087 -0.1
A177-K185 ASIGDANIK U - 887.4712 324.0359 1211.5071 2 606.7614 606.7600 -2.2
A177-R190 ASIGDANIKNYSLR U K185 1520.7946 324.0359 1844.8305 3 615.9513 615.9507 -1.0
A177-R190 ASIGDANIKNYSLR UU	-H2O N183-I184 1520.7946 612.0506 2132.8452 3 711.9562 711.9552 -1.4
A177-R190 ASIGDANIKNYSLR UU K185 1520.7946 630.0612 2150.8558 3 717.9597 717.9589 -1.1
I195-R264 ILSLDADSLFDGNASVR U	-H2O F257 1791.9002 306.0253 2097.9255 3 700.3163 700.3157 -0.9
I195-R264 ILSLDADSLFDGNASVR U F257 1791.9002 324.0359 2115.9361 2 1058.9759 1058.9751 -0.7
I195-R264 ILSLDADSLFDGNASVR UU - 1791.9002 630.0612 2421.9614 2 1211.9885 1211.9821 -5.3
Q321-K333 QNSFRPVFLNYFK U R325 1658.8568 324.0359 1982.8927 3 661.9720 661.9710 -1.6
Q321-K333 QNSFRPVFLNYFK UU R325 1658.8568 630.0612 2288.9180 3 763.9805 763.9799 -0.7
Q321-K333 QNSFRPVFLNYFK UUU - 1658.8568 936.0865 2594.9433 3 865.9889 865.9880 -1.0
Q321-K333 QNSFRPVFLNYFK UUUU - 1658.8568 1242.1118 2900.9686 3 967.9973 967.9963 -1.1
T334-R339 TTLYHR U	-H2O L336 789.4133 306.0253 1095.4386 2 548.7271 548.7262 -1.6
T334-R339 TTLYHR U Y337 789.4133 324.0359 1113.4492 2 557.7324 557.7317 -1.3
T334-R339 TTLYHR UU	-H2O L336 789.4133 612.0506 1401.4639 2 701.7398 701.7386 -1.6
T334-R339 TTLYHR UU Y337 789.4133 630.0612 1419.4745 2 710.7450 710.7444 -0.9
T334-R341 TTLYHRVR U R339 1044.5828 324.0359 1368.6187 3 457.2140 457.2134 -1.4
T334-R341 TTLYHRVR UU - 1044.5828 630.0612 1674.6440 3 559.2225 559.2217 -1.3
F345-K366 FRIVLAENGFDLNTLSAIWAEK U - 2506.3219 324.0359 2830.3578 3 944.4604 944.4581 -2.4
I347-K366 IVLAENGFDLNTLSAIWAEK U	-H2O - 2203.1524 306.0253 2509.1777 3 837.4004 837.3993 -1.3
I347-K366 IVLAENGFDLNTLSAIWAEK UU - 2203.1524 630.0612 2833.2136 3 945.4123 945.4111 -1.3
N367-R380 NIEGLDIALQSIGR U	-H2O I373 1497.8150 306.0253 1803.8403 2 902.9280 902.9282 0.3
N367-R380 NIEGLDIALQSIGR U I373 1497.8150 324.0359 1821.8509 2 911.9333 911.9330 -0.3
N367-K382 NIEGLDIALQSIGRLK U - 1738.9940 324.0359 2063.0299 2 1032.5228 1032.5226 -0.1
N367-K382 NIEGLDIALQSIGRLK UU G379-R380 1738.9940 630.0612 2369.0552 2 1185.5354 1185.5340 -1.2
S383-K400 SKDKAELLELLDSYFDPK U Y396 2110.0833 324.0359 2434.1192 3 812.3809 812.3797 -1.4
D385-K400 DKAELLELLDSYFDPK U	-H2O Y396 1894.9563 306.0253 2200.9816 3 734.6683 734.6675 -1.1
D385-K400 DKAELLELLDSYFDPK U Y396 1894.9563 324.0359 2218.9922 2 1110.5039 1110.5042 0.3
D385-K400 DKAELLELLDSYFDPK UU - 1894.9563 630.0612 2525.0175 3 842.6803 842.6804 0.1
D385-K401 DKAELLELLDSYFDPKK U - 2023.0513 324.0359 2347.0872 3 783.3702 783.3700 -0.3
D385-K401 DKAELLELLDSYFDPKK UU - 2023.0513 630.0612 2653.1125 3 885.3786 885.3796 1.1
A387-K401 AELLELLDSYFDPK U	-H2O Y396 1651.8344 306.0253 1957.8597 2 979.9377 979.9383 0.7
A387-K401 AELLELLDSYFDPK U Y396 1651.8344 324.0359 1975.8703 2 988.9430 988.9430 0.1
A387-K401 AELLELLDSYFDPK UU - 1651.8344 630.0612 2281.8956 2 1141.9556 1141.9540 -1.4
A387-K402 AELLELLDSYFDPKK U	-H2O Y396-S397 1779.9294 306.0253 2085.9547 3 696.3260 696.3253 -1.1
A387-K402 AELLELLDSYFDPKK U Y396 1779.9294 324.0359 2103.9653 2 1052.9905 1052.9891 -1.3
A387-K402 AELLELLDSYFDPKK UUU - 1779.9294 936.0865 2716.0159 3 906.3464 906.3455 -1.0
K401-K409 KTTVKPVVK U - 998.6487 324.0359 1322.6846 2 662.3501 662.3497 -0.6
K401-K409 KTTVKPVVK UU - 998.6487 630.0612 1628.7099 3 543.9111 543.9105 -1.1
K401-K409 KTTVKPVVK UUU - 998.6487 936.0865 1934.7352 2 968.3754 968.3756 0.2
T402-K409 TTVKPVVK U T402-T403 870.5538 324.0359 1194.5897 2 598.3027 598.3020 -1.1
T402-K409 TTVKPVVK UU - 870.5538 630.0612 1500.6150 2 751.3153 751.3148 -0.6
T402-R419 TTVKPVVKGNSNNNNNYR UUU - 2018.0293 936.0865 2954.1158 3 985.7131 985.7140 1.0
G410-R419 GNSNNNNNYR U Y418 1165.4860 324.0359 1489.5219 2 745.7688 745.7683 -0.6
Q428-K451 QSVKDARPSSSPSASTEFGAGGDK U	-H2O - 2365.1145 306.0253 2671.1398 3 891.3877 891.3857 -2.3
Q428-K451 QSVKDARPSSSPSASTEFGAGGDK UU	-HPO3 - 2365.1145 550.0948 2915.2093 3 972.7442 972.7439 -0.4
Q428-K451 QSVKDARPSSSPSASTEFGAGGDK UU - 2365.1145 630.0612 2995.1757 3 999.3997 999.3980 -1.7
Q428-K451 QSVKDARPSSSPSASTEFGAGGDK UUU	-HPO3 - 2365.1145 856.1201 3221.2346 3 1074.7527 1074.7502 -2.3
Q428-K451 QSVKDARPSSSPSASTEFGAGGDK UUU - 2365.1145 936.0865 3301.2010 3 1101.4081 1101.4108 2.4
D432-K451 DARPSSSPSASTEFGAGGDK U	-HPO3 F445 1922.8605 244.0695 2166.9300 3 723.3178 723.3147 -4.3
D432-K451 DARPSSSPSASTEFGAGGDK U	-H2O P435-S436 1922.8605 306.0253 2228.8858 3 743.9697 743.9690 -1.0
D432-K451 DARPSSSPSASTEFGAGGDK U F445 1922.8605 324.0359 2246.8964 3 749.9733 749.9729 -0.5
D432-K451 DARPSSSPSASTEFGAGGDK UU	-H3PO4 - 1922.8605 532.0843 2454.9448 3 819.3227 819.3245 2.2
D432-K451 DARPSSSPSASTEFGAGGDK UU	-HPO3 - 1922.8605 550.0948 2472.9553 3 825.3262 825.3253 -1.1
D432-K451 DARPSSSPSASTEFGAGGDK UU	-H2O P435-S436 1922.8605 612.0506 2534.9111 3 845.9782 845.9779 -0.3
D432-K451 DARPSSSPSASTEFGAGGDK UU F445 1922.8605 630.0612 2552.9217 3 851.9817 851.9810 -0.8
D432-K451 DARPSSSPSASTEFGAGGDK UUU	-HPO3 - 1922.8605 856.1201 2778.9806 3 927.3347 927.3344 -0.3
D432-K451 DARPSSSPSASTEFGAGGDK UUU	-H2O P435-S438 1922.8605 918.0759 2840.9364 3 947.9866 947.9858 -0.8
D432-K451 DARPSSSPSASTEFGAGGDK UUU - 1922.8605 936.0865 2858.9470 3 953.9901 953.9894 -0.8
D432-R453 DARPSSSPSASTEFGAGGDKSR U - 2165.9937 324.0359 2490.0296 3 831.0177 831.0165 -1.4
D432-R453 DARPSSSPSASTEFGAGGDKSR UUU - 2165.9937 936.0865 3102.0802 3 1035.0345 1035.0349 0.4
S454-K464 SVSSLPDSTTK U	-H2O - 1120.5611 306.0253 1426.5864 2 714.3010 714.3003 -1.0
S454-K464 SVSSLPDSTTK U - 1120.5611 324.0359 1444.5970 2 723.3063 723.3042 -2.9
S454-R472 SVSSLPDSTTKTPSPNKPR UU - 1998.0381 630.0612 2628.0993 3 877.0409 877.0411 0.2
S454-R472 SVSSLPDSTTKTPSPNKPR UUU - 1998.0381 936.0865 2934.1246 3 979.0493 979.0487 -0.6
T465-R472 TPSPNKPR UU	-HPO3 - 895.4875 550.0948 1445.5823 2 723.7990 723.7983 -0.9
T465-R472 TPSPNKPR UU - 895.4875 630.0612 1525.5487 2 763.7821 763.7817 -0.6
T465-R472 TPSPNKPR UUU - 895.4875 936.0865 1831.5740 2 916.7948 916.7940 -0.9
N478-K491 NSRQSLGATPNGLK U - 1441.7637 324.0359 1765.7996 3 589.6077 589.6069 -1.3
N478-K491 NSRQSLGATPNGLK UU - 1441.7637 630.0612 2071.8249 3 691.6161 691.6144 -2.4
Q481-K491 QSLGATPNGLK U	-H2O L490 1084.5876 306.0253 1390.6129 2 696.3143 696.3134 -1.2
Q481-K491 QSLGATPNGLK U - 1084.5876 324.0359 1408.6235 2 705.3196 705.3188 -1.1
Q481-K491 QSLGATPNGLK UU - 1084.5876 630.0612 1714.6488 2 858.3322 858.3331 1.1
